期刊文献+

金雀异黄素通过雌激素受体β增加人成骨细胞护骨素与破骨细胞分化因子表达比值 被引量:1

Genistein Increases the Ratios of OPG/RANKL Expression through ER-β in Human Osteoblast
下载PDF
导出
摘要 目的探讨植物雌激素———金雀异黄素(genistein)对人成骨细胞(HOB)作用的分子机制。方法采用细胞培养结合Western blot方法,观察不同浓度金雀异黄素对HOB细胞的护骨素(OPG)、破骨细胞分化因子(RANKL)、雌激素受体(ER-,αER-β)蛋白质的影响。结果①中、大剂量金雀异黄素明显上调HOB细胞OPG蛋白质的表达、下调RANKL蛋白质的表达;雌激素受体拮抗剂ICI 182.780(10-8mol/L)拮抗金雀异黄素(10-8mol/L)的上述作用。②大剂量金雀异黄素刺激HOB细胞ER-β蛋白质的表达;各组ER-α蛋白质的表达量与对照组比较,差异无显著性意义(均P>0.05)。③OPG/RANKL比值与金雀异黄素剂量成正相关关系(r=0.694,P<0.05)。结论金雀异黄素通过ER-β上调HOB细胞OPG表达、下调RANKL表达,该雌激素样效应可能是其抗骨质疏松作用的分子机制之一。 Objective To investigate the effects of phytoestrogenic genistein on OPG/RANKL expression in human osteoblast (HOB). Methods The expression of osteoprotegerin (OPG), receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) and estrogen receptor (ER-α, ER-β) was detected by Western blot in human osteoblast. Results ① Genistein with moderate and high level down-regulated the expression of RANKL protein and up-regulated OPG protein in HOB. The estrogen receptor antagonist ICI 182. 780 blocked the effects of 10^-8 mol/L genistein. ②10^-6 mol/L genistein up-regulated the expression of ER-β protein in HOB. The expression of ER-α protein in HOB treated with genistein had no significant difference in comparison to control group (P〉0.05). ②Ratios of OPG to RANKL were found to be significantly correlated to the genistein levels (r=0. 694, P〈0.05). Conclusion The effect of genistein is similar to estrogen on the expression of RANKL and OPG in HOB, which is possibly the mechanism on preventing bone mass loss.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2006年第3期321-323,327,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 湖北省自然科学基金资助项目(No.2004ABA251)
关键词 金雀异黄素 人成骨细胞 护骨素 破骨细胞分化因子 雌激素受体 genistein human osteoblast osteoprotegerin receptor activator of nuclear factor -kappaB ligand estrogen receptor
  • 相关文献

参考文献15

  • 1BRZEZINSKI A, DEBI A. Phytoestrogens: the 'natural'selective estrogen receptor modulators[J]? Eur J Obstet Gynecol Reprod Biol, 1999, 85(1): 47-51.
  • 2ANDERSON D M, MARASKOVSKY E, BILLINGSLEY W L, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function[J]. Nature,1997, 390(6656): 175-179.
  • 3SIMONET W S, LACEY D L, DUNSTAN C R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density[J]. Cell, 1997, 89(2):309-319.
  • 4KREIJKAMP-KASPERS S, KOK L, GROBBEE D E, et al.Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial[J]. JAMA, 2004,292(1):65-74.
  • 5COTTER A, CASHMAN K D. Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy[J]. Nutr Rev, 2003, 61(10):346-351.
  • 6SUGIMOTO E, YAMAGUCHI M. Anabolic effect of genistein in osteoblastic MC3T3 E1 cells[J].Int J Mol Med,2000, 5(5): 515-520.
  • 7GAO Y H, YAMAGUCHI M. Inhibitory effect of genistein on osteoclast-like cell formation in mouse marrow cultures[J]. Biochem Pharmacol, 1999, 58(5) :767-772.
  • 8YASUDA H, SHIMA N, NAKAGAWA N, et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro [J]. Endocrinology, 1998, 139(3) : 1329-1337.
  • 9KHOSLA S. The OPG/RANKL/RANK system[J]. Endocrinology, 2001, 142(12) :5050-5055.
  • 10BORD S, IRELAND D C, BEAVAN S R, et al. The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts[J]. Bone, 2003, 32(2):136-141.

同被引文献18

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部